# Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

> **NCT06798805** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 110 (actual)

## Conditions studied

- Essential Thrombocythemia (ET)
- Myelofibrosis (MF)
- Polycythemia Vera (PV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06798805
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-15
- **Primary completion:** 2024-08-08
- **Final completion:** 2025-08
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798805, "Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06798805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*